period (as of June 30, 2020 and 2019, respectively). 6. Loss arising from changes in fair value of biological assets increased by Baht 4.73 million compared with the same period of the previous year

by the end of accounting period (as of December 31, 2018 and 2017). - Other income from gain arising from change in fair value of biological assets which increased by amount of Baht 12 million

% Investment in associated company 483.96 36% 474.65 7% Property, plant and equipment 558.59 42% 557.68 5% Biological assets – dairy cow 44.28 3% 38.56 3% Others 61.09 4% 52.82 4% Total assets 1,345.45 100

8.34 million, or 26.62%, in the year 2021 cause was more commission income in of 2021, which decreased by Baht 12.76 million and gain from changes in fair value of biological assets - dairy cow to Baht

higher revenue per visit of non-social security category but also from the efficient cost control of medicine and supplies as well as staff. Administrative Expenses Administrative expenses decreased by 13

IPD which generated highest margin comparing to other categories. Moreover, the efficient cost management such as medicine & medical supplies as well as the benefit from economy of scale in term of

Laboratories Co., Ltd. is a listed company established in the year 1971. The manufacture and distribution of conventional medicine. Office and Factory are located at No.47 Soi Boonchana, Sukhumvit 59, Klong Ton

investment of ward renovation and medical equipment while revenue contracted. However, percent of medicine & supplies and doctor’s fee cost to revenue decreased on back of fewer number of SW patients visit

, compared to the same period of the previous year had amount of Baht 7 million, increased by amount of Baht 14 million. 3. Other incomes from gain arising from change in fair value of biological assets which

of biological assets to ensure its appropriateness. EE is also required to rectify the financial statements for the year 2023 and the third quarter of 2024 and then submit the rectified financial